1.上海中医药大学附属岳阳中西医结合医院(上海 200437)
阿格尔,女,在读硕士生,主要从事中医药防治恶性肿瘤临床研究
龚亚斌,主任医师,博士生导师;E-mail: gongyabin@hotmail.com
扫 描 看 全 文
阿格尔,焦丽静,周海伦等.肺部磨玻璃结节中西医诊疗现状[J].上海中医药大学学报,2023,37(04):64-70.
A Geer,JIAO Lijing,ZHOU Hailun,et al.Current status of traditional Chinese medicine and western medicine in diagnosis and treatment of pulmonary ground⁃glass nodule[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(04):64-70.
阿格尔,焦丽静,周海伦等.肺部磨玻璃结节中西医诊疗现状[J].上海中医药大学学报,2023,37(04):64-70. DOI: 10.16306/j.1008-861x.2023.04.008.
A Geer,JIAO Lijing,ZHOU Hailun,et al.Current status of traditional Chinese medicine and western medicine in diagnosis and treatment of pulmonary ground⁃glass nodule[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(04):64-70. DOI: 10.16306/j.1008-861x.2023.04.008.
随着人们健康意识的提高及低剂量 CT作为肺癌筛查手段的推广,肺部磨玻璃结节(GGN)的检出率逐步增高,而肺部GGN与肺腺癌关系较为密切,故临床中肺部GGN的及时诊治对阻断炎-癌转化具有重要的作用。从肺部GGN的中医认识、风险因素、恶变机制、诊断及中西医治疗等角度进行总结,探讨GGN的中西医诊疗现状。鉴于目前西医治疗GGN以随访观察为主,中医药尚无成熟的诊疗标准,故亟须确立有效可行的肺部GGN中西医结合诊疗方案。
With the improvement of people's health awareness and the popularization of low-dose CT as a means of pulmonary cancer screening, the detection rate of pulmonary ground-glass nodule (GGN) is gradually increasing. While the pulmonary GGN is closely related to pulmonary adenocarcinoma, so timely diagnosis and treatment of pulmonary GGN in clinical practice play an important role in blocking the transformation of inflammatory to cancer. This paper summarizes the current status of traditional Chinese medicine and western medicine in diagnosis and treatment of pulmonary GGN from the following aspects: understanding of traditional Chinese medicine, risk factors, mechanisms of malignancy, diagnosis and traditional Chinese medicine and western medicine treatment. In view of the fact that western medicine treatment of GGN is mainly based on follow-up observation, and traditional Chinese medicine has no mature diagnosis and treatment standard, so it is urgent to establish an effective and feasible plan for diagnosis and treatment of GGN with the integration of traditional Chinese medicine and western medicine.
肺部磨玻璃结节中医西医诊断治疗
pulmonary ground-glass noduletraditional Chinese medicinewestern medicinediagnosistreatment
SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7): 783-791.
CALLISTER M E, BALDWIN D R, AKRAM A R, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules[J]. Thorax, 2015, 70(Suppl 2):ii1-ii54.
NAIDICH D P, BANKIER A A, MACMAHON H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society[J]. Radiology, 2013, 266(1): 304-317.
张晓菊. 《肺结节诊治中国专家共识(2018版)》解读[J]. 中华实用诊断与治疗杂志, 2019, 33(1): 1-3.
ZHANG X J. Interpretation of Chinese expert consensus on the diagnosis and treatment of pulmonary nodules (2018 version)[J]. Journal of Chinese Practical Diagnosis and Therapy, 2019, 33(1): 1-3.
BAI C, CHOI C M, CHU C M, et al. Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia[J]. Chest, 2016, 150(4): 877-893.
周清华, 范亚光, 王颖, 等. 中国肺部结节分类、诊断与治疗指南(2016年版)[J]. 中国肺癌杂志, 2016, 19(12): 793-798.
ZHOU Q H, FAN Y G, WANG Y, et al. China national guideline of classification, diagnosis and treatment for lung nodules (2016 version)[J]. Chinese Journal of Lung Cancer, 2016, 19(12): 793-798.
王群. 肺部磨玻璃结节的诊治策略[J]. 中国肺癌杂志, 2018, 21(3): 160-162.
WANG Q. Management strategies of pulmonary ground galss nodule[J]. Chinese Journal of Lung Cancer, 2018, 21(3): 160-162.
HENSCHKE C I, YANKELEVITZ D F, MIRTCHEVA R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules[J]. AJR Am J Roentgenol, 2002, 178(5): 1053-1057.
PAŚNIK M, BESTRY I, ROSZKOWSKI-ŚLIŻ K. Solitary pulmonary nodule—the role of imaging in the diagnostic process[J]. Adv Respir Med, 2017, 85(6): 345-351.
刘宝东. 肺多发磨玻璃结节的诊治策略[J]. 中国肺癌杂志, 2020, 23(8): 679-684.
LIU B D. Diagnosis and treatment of pulmonary multifocal ground-glass nodules[J]. Chinese Journal of Lung Cancer, 2020, 23(8): 679-684.
徐国厚, 黄海峡, 陈斌, 等. 单体检中心23 695例体检者首次胸部低剂量CT筛查结果及肺结节相关易感因素的研究[J]. 复旦学报: 医学版, 2020, 47(5): 654-659, 668.
XU G H, HUANG H X, CHEN B, et al. A study on the first chest low-dose CT screening and susceptible factors of pulmonary nodules in 23 695 physical examinees in a medical examination center[J]. Fudan University Journal of Medical Sciences, 2020, 47(5): 654-659, 668.
FAN L, WANG Y, ZHOU Y, et al. Lung Cancer Screening with Low-Dose CT: Baseline Screening Results in Shanghai[J]. Acad Radiol, 2019, 26(10): 1283-1291.
赵俊松, 崔利, 何江波, 等. 上海22 351例无症状体检者低剂量CT肺癌筛查及随访结果初步分析[J]. 诊断学理论与实践, 2019, 18(2): 183-188.
ZHAO J S, CUI L, HE J B, et al. Lung cancer screening by low-dose CT in asymptomatic population undergoing physical examination: preliminary analysis of 22 351 cases in Shanghai[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 183-188.
KINSINGER L S, ANDERSON C, KIM J, et al. Implementation of lung cancer screening in the Veterans Health Administration[J]. JAMA Intern Med, 2017, 177(3): 399-406.
黄俊浩, 曾梓苑, 陈生. 扶正散结法联合自血疗法治疗肺结节的临证经验[J]. 广州中医药大学学报, 2022, 39(8): 1858-1862.
HUANG J H, ZENG Z Y, CHEN S. Clinical experience of Fuzheng Sanjie Method combined with autohemo-therapy in the treatment of pulmonary nodule[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2022, 39(8): 1858-1862.
亓润智, 赵雨薇, 栾美琪, 等. 花宝金调气解毒治疗肺结节思想探析[J]. 世界中医药, 2022, 17(11): 1535-1539.
QI R Z, ZHAO Y W, LUAN M Q, et al. Professor Hua Baojin's thought in treating pulmonary nodules by regulating qi and removing toxin[J]. World Chinese Medicine, 2022, 17(11): 1535-1539.
赵芬慈, 陈晶晶, 胡学军. 胡学军治疗肺结节经验[J]. 湖南中医杂志, 2022, 38(5): 45-48.
ZHAO F C, CHEN J J, HU X J. Hu Xuejun's experience in treating pulmonary nodules[J]. Hunan Journal of Traditional Chinese Medicine, 2022, 38(5): 45-48.
易玲, 潘博, 唐蔚, 等. 国医大师潘敏求治疗肺结节经验[J]. 湖南中医杂志, 2022, 38(9): 45-48.
YI L, PAN B, TANG W, et al. Chinese medicine master, Pan Minqiu's experience in treating pulmonary nodules[J]. Hunan Journal of Traditional Chinese Medicine, 2022, 38(9): 45-48.
魏华民, 朱瑞丽, 刘瑞, 等. 从痰瘀窠囊论治肺结节[J]. 世界中医药, 2018, 13(11): 2701-2705, 2708.
WEI H M, ZHU R L, LIU R, et al. Pulmonary Nodule Treatment Based on “Phlegm and Blood Stasis” and “Kenang” Theory[J]. World Chinese Medicine, 2018, 13(11): 2701-2705, 2708.
胡家蕊, 张晓梅, 李梦乾, 等. 姜良铎从通从毒论治肺结节[J]. 中医杂志, 2021, 62(22): 1956-1959.
HU J R, ZHANG X M, LI M Q, et al. Professor Jiang Liangduo's experience in treating pulmonary nodules by keeping unobstructed state and dealing with toxin[J]. Journal of Traditional Chinese Medicine, 2021, 62(22): 1956-1959.
梁艳霞, 代昭欣, 樊茂蓉, 等. 王书臣运用伏邪理论辨治肺结节经验[J]. 中医杂志, 2022, 63(15): 1416-1419.
LIANG Y X, DAI Z X, FAN M R, et al. Wang Shuchen's experience in differentiation and treatment of pulmonary nodules from the latent pathogen theory[J]. Journal of Traditional Chinese Medicine, 2022, 63(15): 1416-1419.
周杰, 王玥慧, 李志明, 等. 络病学说指导下的肺结节“肺气亏虚,毒阻肺络”病机探讨[J]. 中国医药导报, 2020, 17(28): 133-136.
ZHOU J, WANG Y H, LI Z M, et al. Discussion on the pathogenesis of pulmonary nodules “deficiency of lung qi and obstruction of lung collaterals by toxin” under the guidance of collateral disease theory[J]. China Medical Herald, 2020, 17(28): 133-136.
洪海都, 刘城鑫, 吴鹏, 等. 刘小虹辨治肺结节中医特色探析[J]. 中国中医基础医学杂志, 2020, 26(4): 539-541.
HONG H D, LIU C X, WU P, et al. Liu Xiaohong's traditional Chinese medicine characteristics in treating pulmonary nodules based on differentiation and treatment[J]. Journal of Basic Chinese Medicine, 2020, 26(4): 539-541.
SLATORE C G, GOLDEN S E, GANZINI L, et al. Distress and patient-centered communication among veterans with incidental (not screen-detected) pulmonary nodules. A cohort study[J]. Ann Am Thorac Soc, 2015, 12(2): 184-192.
王丽娜, 韦媛媛, 胡华青, 等. 肺结节患者焦虑抑郁与Th17/Treg和炎症水平改变的相关性研究[J]. 中国肺癌杂志, 2020, 23(7): 554-560.
WANG L N, WEI Y Y, HU H Q, et al. Correlation between anxiety, depression and changes in Th17/Treg and inflammatory levels in patients with pulmonary nodules[J]. Chinese Journal of Lung Cancer, 2020, 23(7): 554-560.
MICHOPOULOS V, POWERS A, GILLESPIE C F, et al. Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond[J]. Neuropsychopharmacology, 2017, 42(1): 254-270.
潘越, 江启成. 健康体检人群肺结节检出情况及影响因素分析[J]. 预防医学情报杂志, 2020, 36(3): 356-359, 364.
PAN Y, JIANG Q C. Analysis of the detection of pulmonary nodules and its influencing factors in physical examination population[J]. Journal of Preventive Medicine Information, 2020, 36(3): 356-359, 364.
钟文英, 林秋娥, 王黎平, 等. 健康体检人群肺部结节发生的影响因素分析[J]. 福建医药杂志, 2019, 41(2): 140-142.
ZHONG W Y, LIN Q E, WANG L P, et al. Analysis of influencing factors of pulmonary nodules in healthy people[J]. Fujian Medical Journal, 2019, 41(2): 140-142.
季明, 王媛慧, 周洁, 等. 教师体检人群肺结节检出结果及影响因素分析[J]. 现代肿瘤医学, 2022, 30(16): 2933-2937.
JI M, WANG Y H, ZHOU J, et al. Analysis on the result and influencing factors of pulmonary nodules in teachers' physical examination[J]. Journal of Modern Oncology, 2022, 30(16): 2933-2937.
张丹阳, 徐锦江. 锦州市体检人群肺磨玻璃结节患病情况及影响因素分析[J]. 中国初级卫生保健, 2021, 35(12): 55-57.
ZHANG D Y, XU J J. Analysis on influencing factors of pulmonary ground glass nodules in physical examination population in Jinzhou[J]. Chinese Primary Health Care, 2021, 35(12): 55-57.
曾路情, 夏苏建, 彭锐豪, 等. 2006—2016年中国人群肺癌影响因素的Meta分析[J]. 华南预防医学, 2018, 44(5): 431-435.
ZENG L Q, XIA S J, PENG R H, et al. Meta analysis of influencing factors of lung cancer in China from 2006 to 2016[J]. South China Journal of Preventive Medicine, 2018, 44(5): 431-435.
DENG Y, PENG L, LI N, et al. Tracheal, bronchus, and lung cancer burden and related risk factors in the United States and China[J]. Am J Transl Res, 2021, 13(4): 1928-1951.
史景云, 孙奋勇, 刘海鹏, 等. 肺部多发磨玻璃结节中西医结合防治一体化专家共识[J]. 肿瘤, 2022, 42(7): 451-465.
SHI J Y, SUN F Y, LIU H P, et al. Expert consensus on the diagnosis and treatment of pulmonary multiple ground-glass nodules by integrated traditional Chinese and western medicine[J]. Tumor, 2022, 42(7): 451-465.
SHARMA S V, BELL D W, SETTLEMAN J, et al. Epidermal growth factor receptor mutations in lung cancer[J]. Nat Rev Cancer, 2007, 7(3): 169-181.
HARRISON P T, VYSE S, HUANG P H. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer[J]. Semin Cancer Biol, 2020, 61: 167-179.
GIBBONS D L, BYERS L A, KURIE J M. Smoking, p53 mutation, and lung cancer[J]. Mol Cancer Res, 2014, 12(1): 3-13.
DE MELLO R A, COSTA B M, REIS R M, et al. Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies[J]. Recent Pat Anticancer Drug Discov, 2012, 7(1): 118-131.
XING X, YANG F, HUANG Q, et al. Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing[J]. Sci Adv, 2021, 7(5): eabd9738.
KIM N, KIM H K, LEE K, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma[J]. Nat Commun, 2020, 11(1): 2285.
WISTUBA I I, BEHRENS C, VIRMANI A K, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints[J]. Cancer Res, 2000, 60(7): 1949-1960.
刘敬伟, 张西宁. 肺结节诊断方法的最新进展[J]. 中华外科杂志, 2022, 60(5): 498-503.
LIU J W, ZHANG X N. Recent advances in diagnosis of pulmonary nodule[J]. Chinese Journal of Surgery, 2022, 60(5): 498-503.
BACH P B, MIRKIN J N, OLIVER T K, et al. Benefits and harms of CT screening for lung cancer: a systematic review[J]. JAMA, 2012, 307(22): 2418-2429.
MACMAHON H, NAIDICH D P, GOO J M, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017[J]. Radiology, 2017, 284(1): 228-243.
GOULD M K, DONINGTON J, LYNCH W R, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2013, 143(5 Suppl): e93S-e120S.
中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2018年版)[J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.
Lung Cancer Group, Respiratory Branch, Chinese Medical Association; China Lung Cancer Prevention and Treatment Alliance Expert Group. China expert consensus on diagnosis and treatment of pulmonary nodules (2018 edition)[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2018, 41(10): 763-771.
GANTI A K P, LOO B W, BASSETTI M, et al. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2021, 19(12): 1441-1464.
中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2022版)[J]. 中华肿瘤杂志, 2022, 44(6): 457-490.
Oncology Society of Chinese Medical Association, Chinese Medical Association Publishing House. Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition)[J]. Chinese Journal of Oncology, 2022, 44(6): 457-490.
TRAVIS W D, BRAMBILLA E, NOGUCHI M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma[J]. J Thorac Oncol, 2011, 6(2): 244-285.
姜格宁, 陈昶, 朱余明, 等. 上海市肺科医院磨玻璃结节早期肺腺癌的诊疗共识(第一版)[J]. 中国肺癌杂志, 2018, 21(3): 147-159.
JIANG G N, CHEN C, ZHU Y M, et al. Shanghai pulmonary hospital experts consensus on the management of ground-glass nodules suspected as lung adenocarcinoma (version 1)[J]. Chinese Journal of Lung Cancer, 2018, 21(3): 147-159.
林博裕, 谷志涛, 方文涛. 亚肺叶切除在含磨玻璃样成分的早期肺腺癌中的研究现状及进展[J]. 中华医学杂志, 2021, 101(33): 2641-2644.
LIN B Y, GU Z T, FANG W T. Research status and progress of lobectomy in early lung adenocarcinoma with ground glass-like components[J]. National Medical Journal of China, 2021, 101(33): 2641-2644.
俞浩洋, 朱慧志, 韩磊玲, 等. 胡国俊治疗肺结节处方用药规律研究[J]. 中医药临床杂志, 2022, 34(9): 1695-1699.
YU H Y, ZHU H Z, HAN L L, et al. Study on the prescription law of professor Hu Guojun in the treatment of pulmonary nodules based on apriori association rules and cluster analysis[J]. Clinical Journal of Traditional Chinese Medicine, 2022, 34(9): 1695-1699.
林事成, 周相男, 刘殿娜, 等. 基于络病理论探讨肺结节结癌转化的防治[J]. 中医学报, 2022, 37(9): 1825-1828.
LIN S C, ZHOU X N, LIU D N, et al. Discussion on prevention and treatment of nodule-cancer transformation of pulmonary nodules based on collateral disease theory[J]. Acta Chinese Medicine, 2022, 37(9): 1825-1828.
任毅, 陈勇, 祝海毅, 等. 罗玲主任医师治疗肺结节用药规律的聚类分析[J]. 中国中医药现代远程教育, 2021, 19(2): 72-75.
REN Y, CHEN Y, ZHU H Y, et al. Clustering analysis of the rule of using medicine for pulmonary nodules by chief physician Luo Ling[J]. Chinese Medicine Modern Distance Education of China, 2021, 19(2): 72-75.
黄文博, 田思雨, 陈云凤, 等. 基于“金郁泄之”探讨肺结节的病机及风药的应用[J]. 北京中医药大学学报, 2023, 46(3): 336-339.
HUANG W B, TIAN S Y, CHEN Y F, et al. Discussion on the pathogenesis of pulmonary nodules and the application of wind-drugs based on the theory of “stasis of metal should be adjusted”[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023, 46(3): 336-339.
赵峰云, 张盼盼, 郑小伟. 肺结节病临证辨治体会[J]. 浙江中医杂志, 2018, 53(2): 121.
ZHAO F Y, ZHANG P P, ZHENG X W. Experience of syndrome differentiation and treatment of pulmonary sarcoidosis[J]. Zhejiang Journal of Traditional Chinese Medicine, 2018, 53(2): 121.
裴昆, 韩啸, 巫浣宜. 巫浣宜治疗肺结节验案举隅[J]. 浙江中医杂志, 2020, 55(11): 848-849.
PEI K, HAN X, WU H Y. Examples of Wu Huanyi's experience in treating pulmonary nodules[J]. Zhejiang Journal of Traditional Chinese Medicine, 2020, 55(11): 848-849.
鹿竞文, 徐力. 徐力教授中医治疗肺结节经验[J]. 中医临床研究, 2021, 13(17): 35-38.
LU J W, XU L. Professor Xu Li's experience in treating pulmonary nodules in TCM[J]. Clinical Journal of Chinese Medicine, 2021, 13(17): 35-38.
0
浏览量
129
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构